LipiDiDiet finds broad and sustainable effects of nutrient intervention in early Alzheimer’s disease:
Data published in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association

The European LipiDiDiet project addresses the Impact of Nutritional Lipids on Neuronal and Cognitive Performance in Aging, Alzheimer’s disease and Vascular Dementia. This is based on previous observations that lipids change the risk for dementia. Especially some omega-3 lipids appear to lower the Alzheimer risk. It is our major aim to complement the currently existing medical therapy of Alzheimer’s disease with nutrition, especially at the very first stages of Alzheimer’s disease. But we do not stop at Alzheimer’s, we also develop dietary products that maintain and support the normal cognitive function in healthy aging in general and help reduce cerebrovascular risks. In addition to dietary products we also develop diet and life-style based health care advice for the elderly.

The project is based on two elements; one is applied research documenting the value of nutritional support in persons at risk of getting Alzheimer’s disease. The other element is basic research generating more knowledge about the possible therapeutic and preventive effects of dietary lipids in model systems of Alzheimer’s disease and Vascular Dementia.

Find out more about the project

 Download the LipiDiDiet Factsheet
 Read more about LipiDiDiet in “International Innovation”


This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement No 211696.

This website reflects the views only of the LipiDiDiet Consortium, and does not necessarily represent the view of the European Commission (EC). The Commission cannot be held responsible for any use which may be made of the information contained therein.